-
-
-
-
-
-
-
Enanta Pharmaceuticals Announces Proposed Public Offering of Common Stock
-
-
-
-
-
-
-
Enanta Pharma (ENTA) Announces that AbbVie's (ABBV) MAVIRET Received Approval in Japan for the Treatment of All Major Genotypes (GT1-6) of Chronic HVC
-
-
-
-
-
-
-
Enanta Pharma (ENTA) Commences EDP-494 Proof-of-Concept Study in Two HCV Genotypes
-
-
-
-
-
-
70,557 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

